Lymphatic malformations: Clinical course and management in 64 cases

Australasian Journal of Dermatology

Volumn 52, Issue 3, 2011, Pages 186-190

  Hogeling, Marcia ^a   Adams, Susan ^b   Law, Jenaleen ^c   Wargon, Orli ^a  

^a Department of Paediatric Dermatology ^*  (Australia)

^b SYDNEY CHILDREN'S HOSPITAL   (Australia)

^c UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

Hemihypertrophy; lymphatic malformations; sclerosing solutions; sclerotherapy; surgery; vascular malformations

Indexed keywords

DOXYCYCLINE; PICIBANIL; TETRADECYL SULFATE SODIUM;

ARTICLE; CHILDHOOD DISEASE; CONGENITAL BLOOD VESSEL MALFORMATION; FEMALE; HEALTH SURVEY; HEMIHYPERTROPHY; HUMAN; LYMPHATIC MALFORMATION; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MORBIDITY; ONSET AGE; SCLEROTHERAPY; SKIN BRUISING; SKIN DISCOLORATION; SKIN TUMOR; SWELLING; TELEDERMATOLOGY;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INFANT; LYMPHATIC ABNORMALITIES; MALE; SCLEROTHERAPY; SKIN DISEASES, VASCULAR;

EID: 80051791584     PISSN: 00048380     EISSN: 14400960     Source Type: Journal    
DOI: 10.1111/j.1440-0960.2011.00777.x     Document Type: Article

References (25)

1. Mulliken JB, Glowacki J,. Hemangiomas and vascular malformations in infants and children: a classification based on endothelial characteristics. Plast. Reconstr. Surg. 1982; 69: 412-20.
2. Smith RJH,. Lymphatic malformations. Lymphat. Res. Biol. 2004; 2: 25-31. (Pubitemid 39206643)
3. Garzon MC, Huang JT, Enjolras O, et al,. Vascular Malformations: Part I. J. Am. Acad. Dermatol. 2007; 56: 353-70.
4. Davies D, Rogers M,. Morphology of lymphatic malformations: a pictorial review. Australas. J. Dermatol. 2000; 41: 1-5; quiz 6-7.
5. Hancock BJ, St-Vil D, Luks F, et al,. Complications of lymphangiomas in children. J. Pediatr. Surg. 1992; 27: 220-4. discussion 224-6.
6. Eichenfield LF, Frieden IJ, Esterly NB,. Neonatal dermatology. Philadelphia PA: Saunders, 2008.
7. Limaye N, Boon LM, Vikkula M,. From germline towards somatic mutations in the pathophysiology of vascular anomalies. Hum. Mol. Genet. 2009; 18: 65-74.
8. Orvidas LJ, Kasperbauer JL,. Pediatric lymphangiomas of the head and neck. Ann. Otol. Rhinol. Laryngol. 2000; 109: 411-21. (Pubitemid 30198533)
9. Saijo M, Munro IR, Mancer K,. Lymphangioma. A long-term follow-up study. Plast. Reconstr. Surg. 1975; 56: 642-51.
10. Australian Bureau of Statistics (internet). Australian Social Trends. 2007: Australia's Babies. (released 07/08/2007, accessed 12/01/2011) Available from:.
11. Centre for Epidemiology and Research. NSW Department of Health. New South Wales Mothers and Babies 2006. NSW Public Health Bull 2007; 18: 20.1- 160. (accessed 12/01/2011) Available from:.
12. Emery PJ, Bailey CM, Evans JNG,. Cystic hygroma of the head and neck. A review of 37 cases. J. Laryngol. Otol. 1984; 98: 613-19. (Pubitemid 14079021)
13. Ninh NN, Ninh TX,. Cystic hygroma in children: a report of 126 cases. J. Pediatr. Surg. 1974; 9: 191-5.
14. Upton J, Coombs CJ, Mulliken JB, et al,. Vascular malformations of the upper limb: a review of 270 patients. J. Hand Surg. 1999; 24A: 1019-35. (Pubitemid 29449287)
15. Mathes EFD, Haggstrom AN, Dowd C, et al,. Clinical characteristics and management of vascular anomalies. Arch. Dermatol. 2004; 140: 979-83.
16. Padwa BL, Hayward PG, Ferraro NF, et al,. Cervicofacial lymphatic malformation: clinical course, surgical intervention, and pathogenesis of skeletal hypertrophy. Plast. Reconstr. Surg. 1995; 95: 951-60.
17. Greene AK, Burrows PE, Smith L, et al,. Periorbital lymphatic malformation: clinical course and management in 42 patients. Plast. Reconstr. Surg. 2005; 115: 22-30. (Pubitemid 40187791)
18. Bisdorff A, Mulliken JB, Carrico J, et al,. Intracranial vascular anomalies in patients with periorbital lymphatic and lymphaticovenous malformations. Am. J. Neuroradiol. 2007; 28: 335-41. (Pubitemid 46281058)
19. Rinker B, Karp NS, Margiotta M, et al,. The role of magnetic resonance imaging in the management of vascular malformations of the trunk and extremities. Plast. Reconstr. Surg. 2003; 112: 504-10. (Pubitemid 36951440)
20. Alomari AI, Karian VE, Lord DJ, et al,. Percutaneous sclerotherapy for lymphatic malformations: a retrospective analysis of patient-evaluated improvement. J. Vasc. Interv. Radiol. 2006; 10: 1639-48. (Pubitemid 44581178)
21. Smith MC, Zimmerman MB, Burke DK, et al,. Efficacy and safety of OK-432 immunotherapy of lymphatic malformations. Laryngoscope 2009; 119: 107-15.
22. Okazaki T, Iwatani S, Yanai T, et al,. Treatment of lymphangioma in children: our experience of 128 cases. J. Pediatr. Surg. 2007; 42: 386-9. (Pubitemid 46161564)
23. Peters DA, Courtemanche DJ, Heran MK, et al,. Treatment of cystic lymphatic vascular malformations with OK-432 sclerotherapy. Plast. Reconstr. Surg. 2006; 118: 1441-6. (Pubitemid 44610395)
24. Nehra D, Jacobson L, Barnes P, et al,. Doxycycline sclerotherapy as primary treatment of head and neck lymphatic malformations in children. J. Pediatr. Surg. 2008; 43: 451-60. (Pubitemid 351382049)
25. Shiels WE 2nd, Kang DR, Murakami JW, et al,. Percutaneous treatment of lymphatic malformations. Otolaryngol. Head Neck Surg. 2009; 141: 219-24.